Literature DB >> 16434387

Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.

Ashley P Ng, Stephen Lade, Timothy Rutherford, Christopher McCormack, H Miles Prince, David A Westerman.   

Abstract

CD4+/CD56+ hematodermic neoplasm (WHO-EORTC) or blastic NK-cell lymphoma (WHO) is a rare aggressive (CD4+)(CD56+)lin- skin-tropic lymphoma of putative early-plasmacytoid dendritic cell origin. We present five cases to highlight the need for greater awareness of this entity amongst pathologists such that aggressive treatment be considered given the generally poor prognosis.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16434387

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  11 in total

1.  Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.

Authors:  Ming Sheng Lim; Karla Lemmert; Anoop Enjeti
Journal:  BMJ Case Rep       Date:  2016-01-20

2.  Central nervous system involvement in CD4+/CD56+ hematodermic neoplasm: a report of two cases.

Authors:  Nóra Eros; Márta Marschalkó; Katalin Balassa; Bernadett Hídvégi; József Szakonyi; Sándor Ilniczky; Katalin Borka; Attila Kovács; Gyula Bottlik; Judit Hársing; Judit Csomor; Agota Szepesi; András Matolcsy; Sarolta Kárpáti; Judit Demeter
Journal:  J Neurooncol       Date:  2009-10-02       Impact factor: 4.130

3.  CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer.

Authors:  Chalid Assaf; Sylke Gellrich; Sean Whittaker; Alistair Robson; Lorenzo Cerroni; Cesare Massone; Helmut Kerl; Christian Rose; Andreas Chott; Sergio Chimenti; Christian Hallermann; Tony Petrella; Janine Wechsler; Martine Bagot; Michael Hummel; Katrin Bullani-Kerl; Marcel W Bekkenk; Werner Kempf; Chris J L M Meijer; Rein Willemze; Wolfram Sterry
Journal:  J Clin Pathol       Date:  2006-10-03       Impact factor: 3.411

4.  Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.

Authors:  M R Sapienza; F Fuligni; C Agostinelli; C Tripodo; S Righi; M A Laginestra; A Pileri; M Mancini; M Rossi; F Ricci; A Gazzola; F Melle; C Mannu; F Ulbar; M Arpinati; M Paulli; T Maeda; D Gibellini; L Pagano; N Pimpinelli; M Santucci; L Cerroni; C M Croce; F Facchetti; P P Piccaluga; S A Pileri
Journal:  Leukemia       Date:  2014-02-07       Impact factor: 11.528

5.  Leukemic manifestation of blastic plasmacytoid dendritic cell neoplasm: laboratory approaches in 2 cases.

Authors:  Sang Hyuk Park; Hyun-Sook Chi; Young-Uk Cho; Seongsoo Jang; Chan-Jeoung Park
Journal:  Blood Res       Date:  2014-09-25

6.  Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

Authors:  Livio Pagano; Caterina Giovanna Valentini; Alessandro Pulsoni; Simona Fisogni; Paola Carluccio; Francesco Mannelli; Monia Lunghi; Gianmatteo Pica; Francesco Onida; Chiara Cattaneo; Pier Paolo Piccaluga; Eros Di Bona; Elisabetta Todisco; Pellegrino Musto; Antonio Spadea; Alfonso D'Arco; Stefano Pileri; Giuseppe Leone; Sergio Amadori; Fabio Facchetti
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

7.  Blastic Plasmacytoid Dendritic Cell Neoplasm: Single Center Experience on a Rare Hematological Malignancy.

Authors:  Zehra Narli Ozdemir; Guldane Cengiz Seval; Ugur Sahin; Atilla Uslu; Mehmet Gunduz; Sinem Civriz Bozdag; Selami Kocak Toprak; Meltem Kurt Yuksel; Pervin Topcuoglu; Isinsu Kuzu; Muhit Ozcan; Gunhan Gurman; Osman Ilhan
Journal:  Indian J Hematol Blood Transfus       Date:  2020-07-04       Impact factor: 0.900

8.  Blastic Plasmacytoid Dendritic Cell Neoplasm: Analysis of Clinicopathological Feature and Treatment Outcome of Seven Cases.

Authors:  Jun-Hwan Kim; Hae-Young Park; Jong-Hee Lee; Dong-Youn Lee; Joo-Heung Lee; Jun-Mo Yang
Journal:  Ann Dermatol       Date:  2015-12-07       Impact factor: 1.444

9.  Flow cytometry to identify bone-marrow relapse in blastic plasmacytoid dendritic cell neoplasm: a case report.

Authors:  Mariela Granero Farias; Fabiane Spagnol Pedrazzani; Luis Carlos Zanandrea Contin; Ana Paula Alegretti; Lisandra Della Costa Rigoni; Liane Esteves Daudt
Journal:  Rev Bras Hematol Hemoter       Date:  2017-05-16

10.  Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm.

Authors:  Naveen Pemmaraju; Marina Konopleva
Journal:  Blood Adv       Date:  2020-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.